Investigación

BMC Neurology, 2 July 2021

PBM was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected. Home treatment of PD by the person themselves or with the help of a carer might be an effective therapy option. The results of this study indicate that a large RCT is warranted.

Access the paper here

Journal of Clinical Medicine, April 13, 2023

This remotely run study is the first triple blind RCT assessing efficacy and safety of a novel transcranial PBM device for PD. It was found that tPBM was safe, well tolerated and improved specific motor symptoms for a majority of the sub-scores of the treatment cohort. Current treatments for PD provide limited long-term results, highlighting the need to examine new and less-researched therapies. The use of tPBM to treat symptoms of PD reflects an emerging application of light-based technologies to expand treatment options. The response of some participants to tPBM treatment in this study suggests that further research with a larger trial is needed to build an understanding of the application of tPBM to treat the symptoms of PD. Finally, the characteristics of PD patients who might respond positively to tPBM therapy requires further exploration. The results of this study are encouraging and suggest that tPBM can meaningfully improve individual motor signs of PD and be used as a safe and non-pharmaceutical adjunct treatment for the management of symptoms of PD.

Access the paper here

BMC Neurology, October 9, 2024.

Improvements in clinical signs and symptoms of Parkinson’s disease using photobiomodulation: a five-year follow-up.

This study provides a signal that photobiomodulation therapy might safely reduce important clinical motor signs and non-motor symptoms in some Parkinson’s disease patients, with improvements maintained over several years. Home-based photobiomodulation therapy has the potential to complement standard therapies to manage symptoms and potentially delay Parkinson’s symptom progression.

Access the paper here.